Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis halts Phase III study of heart failure drug LCZ696 early on positive results
Novartis halts Phase III study of heart failure drug LCZ696 early on positive results
Novartis halts Phase III study of heart failure drug LCZ696 early on positive results
Submitted by
admin
on March 31, 2014 - 9:59am
Source:
First Word Pharma
News Tags:
LCZ696
Novartis
heart failure
Headline:
Novartis halts Phase III study of heart failure drug LCZ696 early on positive results
Do Not Allow Advertisers to Use My Personal information
